Dr. Reinaldo Rosario, MD

Dr. Rosario practices at Lauderhill Dialysis in Fort Lauderdale, Florida.

Dr. Rosario's NPI, 1043312853, was assigned on September 2, 2006. Dr. Rosario graduated from Universidad Central del Caribe School of Medicine in 2001. Dr. Rosario holds Florida license ME90872.

Dr. Rosario's primary practice is Lauderhill Dialysis, at 2001 Ne 48th Ct, Fort Lauderdale, FL 33308 in Broward County. The practice phone is (954) 731-6044.

Dr. Rosario's primary practice is Lauderhill Dialysis in Fort Lauderdale, Florida. Dr. Rosario is also affiliated with Broward Health Medical Center. The medical group on file is Florida Kidney Physicians. Dmand AI also links Dr. Rosario to 4 more hospitals, 3 dialysis centers, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Rosario practices, 10 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Rosario's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Rosario is board certified in nephrology by the American Board of Internal Medicine. Dr. Rosario is licensed in Florida.

Dmand AI lists acute kidney failure, chronic kidney disease, fluid and electrolyte imbalances, kidney cysts, kidney disease and parathyroid gland disorder among the conditions Dr. Rosario treats.

CMS data shows 1,330 Medicare services from Dr. Rosario across 9 procedure codes in 2024, for 363 Medicare patients. Medicare paid $111,538 for them.

CMS counts 363 Medicare patients who saw Dr. Rosario in 2024. The largest group is 75 to 84, with 130 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 49% are also on Medicaid. Their average risk score is 5.08, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Rosario's median patient age at 70, with 45% women.

In 2024, Dr. Rosario wrote 1,406 Medicare Part D claims for 230 patients. 77% of them were for generic drugs. CMS names the drug for 1,078 of them, across 33 drugs with 11 or more claims each, at $251,299 in total drug cost. In 2023, CMS named 998 claims across 29 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 90 out of 100 for Dr. Rosario for performance year 2024, reported individually. Dr. Rosario accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Rosario as offering telehealth.

Dmand AI links 5 papers to Dr. Rosario in 2013. The most frequent topics are Photochemotherapy. Dr. Rosario's most frequent co-authors are Alberto Casaretto, MD, Wayne Robert Kotzker, MD and Murray Epstein, MD.

CMS Open Payments shows 700 general payments to Dr. Rosario from 38 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 67% of the total. GlaxoSmithKline, LLC. paid the most, $60,614.

Dmand AI lists 1 award for Dr. Rosario, most recently CMS Stage 1 2012 in 2012.

Dr. Rosario graduated from Universidad Central del Caribe School of Medicine in 2001.

Dr. Rosario is in network with 20 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.